Drugs / Bilberry extract
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT02194361 | Dec 1999 → Jul 2000 | — | Boehringer Ingelheim | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Bilberry extract | “Bilberry extract capsules, 160 mg (25% anthocyanosides)” NCT02194361 ↗ |